China anabolic steroid hormone raw powders professional supplier
Place of Origin: | China |
Brand Name: | pharmrich |
Certification: | ISO9001 |
Model Number: | 616202-92-7 |
Minimum Order Quantity: | 10g |
---|---|
Price: | Negotiable |
Packaging Details: | Disguised package or according to your requirement |
Delivery Time: | within 24 hours after payment |
Payment Terms: | Western union and moneygram,Bank transfer,Bitcoin, T/T |
Supply Ability: | 3000t/month |
Name: | Lorcaserin HCL | CAS: | 616202-92-7 |
---|---|---|---|
MF: | C11H14ClN | MW: | 232.1525 |
Boiling Point :: | 288.125°C At 760 MmHg | Flash Point: | 128.054°C |
Email: | Gavin@pharmrich.com | Whatsapp: | +08618806592208 |
High Light: | CAS 616202-92-7,Lorcaserin HCL Weight Loss Steroids,Lorcaserin Hydrochloride Weight Loss Steroids |
Product Name: Lorcaserin Hcl
English name: Lorcaserin hydrochloride
English Synonyms: (1R) -8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine hydrochloride; APD 356; APD-356; UNII-0QJF08GDPE; Lorcaserin HCl; (R) – 1H-3-Benzazepine, 8-Chloro-2,3,4,5-Tetrahydro-1-Methyl-, Hydrochloride
Appearance:white powder
Boiling point : 288.125°C at 760 mmHg
Flash point : 128.054°C
Product usage : Medicine reducing weight and antidepressants
Product name |
Lorcaserin |
CAS |
616202-92-7 |
Appearance |
yellow oil |
Molecular formula |
C11H14ClN |
Molecular weight |
195.6886 |
Molecular Structure |
|
Boiling point |
288.125oC at 760 mmHg |
Refractive index |
1.527 |
Density |
1.075 g / cm3 |
T3 /Liothyronine sodium/Cytomel | CAS 55-06-1 |
T4/L-Thyroxine | CAS 51-48-9 |
L-Carnitine | CAS 541-15-1 |
DMAA | CAS 13803-74-2 |
Theobromine | CAS 83-67-0 |
Synephrine | CAS 94-07-5 |
Rimonabant | CAS 168273-06-1 |
Lorcaserin HCI | CAS 846589-98-8 |
CLA (Conjugated Linoleic Acid) | CAS 2420-56-6 |
Orlistat | CAS 96829-58-2 |
Furazabol | CAS 12B9-29-8 |
Calcium Pyruvate | CAS 52009-14-0 |
Dextromethorphan Hydrobromide | CAS 6700-34-1 |
Lorcaserin hydrochloride | CAS 846589-98-8 |
Telmisartan | CAS 144701-48-4 |
Lorcaserin is a new drug for the treatment of obesity , belonging to oral potent selective serotonin 2C receptor agonists, lorcaserin hydrochloride is successfully developed by the US company Arena, on June 27, 2012 by the US FDA it is approved for marketing, as adjuvant therapy for obesity or merge with at least one weight-related complications in overweight adults in low-calorie diet and exercise basis . Clinical studies show that the drug can reduce weight of obesity and overweight patients ,it can improve obesity-related metabolic parameters, and it is well tolerated. Lorcaserin affinity for the 5-HT2c 100 times higher than the 5-HT2B (valvular heart disease risk) ,it has good safety,it is the first FDA-approved weight-loss drug after 1999 . In a year of Lorcaserin treatment, the average weight loss ranges from 3 to 3.7 percent.
Contact Person: Gavin Lee
Tel: +8618806592208